Article
The phenotype of a "Cdc2 kinase target site-deficient" mutant of oncoprotein 18 reveals a role of this protein in cell cycle control.
The Journal of biological chemistry - 2 Dec 1994
Marklund U, Osterman O, Melander H, Bergh A, Gullberg M
Abstract excerpt
Oncoprotein 18 (Op18) is a cytosolic protein that is expressed in all proliferating cells. This phosphoprotein is up-regulated in a variety of human neoplasm, and phosphorylation of its two Cdc2 kinase target sites, Ser-25 and Ser-38, fluctuates dramatically during the cell cycle. We have investigated the potential role of the Cdc2 kinase-mediated phosphorylation of these two sites by expressing a "Cdc2 kinase...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
